Jefferies Starts Apollo Medical Holdings (AMEH) at Buy, 'unique model'

Jefferies analyst Jack Slevin initiates coverage on Apollo Medical Holdings (NASDAQ: AMEH) with a Buy rating and a price target of $50.00.

The analyst comments "With diversified payor mix and a long history of execution in value-based care, we think AMEH is an underappreciated & strong operator that should driven results in a high-growth corner of H/C Services over the next few years With a +20% EBITDA growth outlook & strong existing FCF generation, we think AMEH's unique model will garner more attention over the coming 12-24 months closing the valuation gap to more popular peers. Incrementally, we think AMEH's unique model which includes execution of some payor functions gives them a leg up on cost trend visibility vs. other VBC players, a key issue across the space currently."

For an analyst ratings summary and ratings history on Apollo Medical Holdings click here. For more ratings news on Apollo Medical Holdings click here.

Shares of Apollo Medical Holdings closed at $41.70 yesterday.

You May Also Be Interested In

• Freedom Broker Upgrades Alico Inc. (ALCO) to Buy
• Ambiq Micro Inc (AMBQ) PT Raised to $75 at BofA Securities
• Strawberry Fields REIT (STRW) PT Raised to $16 at Freedom Broker